DRD2 activation inhibits choroidal neovascularization in patients with Parkinson's disease and age-related macular degeneration.
Mathis T, Baudin F, Mariet AS, Augustin S, Bricout M, Przegralek L, Roubeix C, Benzenine É, Blot G, Nous C, Kodjikian L, Mauget-Faÿsse M, Sahel JA, Plevin R, Zeitz C, Delarasse C, Guillonneau X, Creuzot-Garcher C, Quantin C, Hunot S, Sennlaub F.
Mathis T, et al. Among authors: creuzot garcher c.
J Clin Invest. 2024 Jul 16;134(17):e174199. doi: 10.1172/JCI174199.
J Clin Invest. 2024.
PMID: 39012703
Free PMC article.